Equity Metals reports 6.1-metre No. 3 Vein intercept grading 1.9 g/t Au and 166 g/t Ag at Silver Queen project in British Columbia
Bitget2026/10/08 11:32Equity Metals reported assays from 17 validation drill holes totaling 5,719 meters on the No. 3 Vein at its Silver Queen project. Top intercepts included 6.1 meters at 1.9 g/t gold, 166 g/t silver, 1.9% lead, 8.6% zinc from hole SQ26-173. Additional highlights included 2.6 meters at 2.6 g/t gold, 310 g/t silver, 0.8% copper from SQ26-171. Q4 2026 drilling is set to start in the second week of October, targeting up to 8 holes for 2,500 meters. A permit amendment enables rehabilitation of the Earl Adit for underground access to support a drone lidar survey planned for late Q4. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Equity Metals Corporation published the original content used to generate this news brief via Newsfile (Ref. ID: 202610080730NEWSFILECNPR____20261008_318043_1) on October 08, 2026, and is solely responsible for the information contained therein.
- Equity Metals reported assays from 17 validation drill holes totaling 5,719 meters on the No. 3 Vein at its Silver Queen project.
- Top intercepts included 6.1 meters at 1.9 g/t gold, 166 g/t silver, 1.9% lead, 8.6% zinc from hole SQ26-173.
- Additional highlights included 2.6 meters at 2.6 g/t gold, 310 g/t silver, 0.8% copper from SQ26-171.
- Q4 2026 drilling is set to start in the second week of October, targeting up to 8 holes for 2,500 meters.
- A permit amendment enables rehabilitation of the Earl Adit for underground access to support a drone lidar survey planned for late Q4.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
